Related Experiment Video
Updated: Jun 12, 2026

Human Liver Microphysiological System for Assessing Drug-Induced Liver Toxicity In Vitro
Published on: January 31, 2022
Developing structure-activity relationships for the prediction of hepatotoxicity
Nigel Greene1, Lilia Fisk, Russell T Naven
1Worldwide Medicinal Chemistry and Drug Safety R&D, Pfizer Global Research and Development, Pfizer Inc., Groton, CT 06340, USA. nigel.greene@pfizer.com
Developing new structure-activity relationships (SARs) for drug-induced liver injury is crucial for early toxicity identification. This study demonstrates the feasibility of using published data to create SARs, aiding in safer drug development.
Area of Science:
- Toxicology
- Medicinal Chemistry
- Computational Chemistry
Background:
- Drug-induced liver injury (DILI) is a significant concern, leading to drug withdrawals.
- Understanding chemical structure-activity relationships (SARs) aids in early toxicity prediction.
- Existing toxicity data is often fragmented and unstructured in scientific literature.
Purpose of the Study:
- To explore the feasibility of collecting and utilizing published data to develop new SARs for hepatotoxicity.
- To expand the limited existing knowledge on SARs for liver toxicity.
- To create a searchable database of hepatotoxicity data.
Main Methods:
- Compiled hepatotoxicity data from literature reviews to build a structure-searchable database.
- Analyzed the database to identify chemical classes associated with liver toxicity.
- Searched literature for additional evidence and incorporated findings into the database.
- Developed SARs for 38 chemical classes based on data for over 1266 chemicals.
- Implemented SARs as structural alerts in Derek for Windows (DfW) for in silico predictions.
Main Results:
- Successfully developed SARs for 38 chemical classes, encompassing data from 1266 chemicals.
- Implemented these SARs as structural alerts within the DfW expert system.
- Evaluation showed 56% overall concordance, with 73% specificity and 46% sensitivity for DfW predictions.
- The approach demonstrated the derivation of SARs for complex endpoints from published data.
Conclusions:
- It is feasible to derive SARs for complex toxicological endpoints like hepatotoxicity from published literature.
- This approach supports in silico toxicity assessment of new chemical entities during drug development.
- The developed SARs, implemented as structural alerts, provide transparent and supported toxicity predictions.
Related Concept Videos
Bioactivation and Tissue Toxicity
Structure-Activity Relationships and Drug Design
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence its...
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Drug toxicity: Drug–Drug Interaction
Phase II Reactions: Glutathione Conjugation and Mercapturic Acid Formation
Several distinctive characteristics distinguish glutathione conjugation from other phase II...
Drug Toxicity: Dose-Dependent Reactions
